7481-89-2
7481-89-2
Chemical Structure
Zalcitabine
Synonym(s): 2',3'-Dideoxycytidine; ddC; Dideoxycytidine
- CAS No.: 7481-89-2
- Formula:C9H13N3O3
- Molecular Weight:211.22
IUPAC Name: 4-amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
InChIKey: WREGKURFCTUGRC-POYBYMJQSA-N
SMILES: OC[C@@H]1CC[C@H](N2C=CC(N)=NC2=O)O1
Biological Activity: Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zalcitabine | 99.81% | Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zalcitabine (Standard) | 98.56% | Zalcitabine (Standard) is the analytical standard of Zalcitabine. This product is intended for research and analytical applications. Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-trans-Lamivudine | (±)-trans-Lamivudine is separated from the salt of (S)-(+) mandelic acid. (±)-trans-Lamivudine forms cocrystals with (S)-BINOL. (±)-trans-Lamivudine is promising for research of human immunodeficiency virus infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Troxacitabine | 99.95% | Troxacitabine is nucleoside analog with potent anticancer activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dideoxycytidinene | 98.36% | Dideoxycytidinene (2′,3′-Didehydro-2′,3′-dideoxycytidine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1-(alpha-L-Threofuranosyl)cytosine | 1-(alpha-L-Threofuranosyl)cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lamivudine | 99.97% | Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lamivudine-13C,15N3 | Lamivudine-13C,15N3 (BCH-189-13C,15N3) is 13C and 15N labeled Lamivudine. Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2',3'-Dideoxyuridine (Standard) | ≥98% | 2',3'-Dideoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lamivudine impurity 5 | Lamivudine impurity 5 is an impurity of Lamivudine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lamivudine-15N2,13C | Lamivudine-15N2,13C (BCH-189-15N2,13C) is 13C and 15N labeled Lamivudine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lamivudine impurity 4 | Lamivudine impurity 4 is an impurity of Lamivudine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
